Acorda Therapeutics
56
0
0
47
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
16.1%
9 terminated/withdrawn out of 56 trials
83.9%
-2.6% vs industry average
30%
17 trials in Phase 3/4
72%
34 of 47 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (56)
Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis
Role: collaborator
A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial
Role: lead
Ampyra for Optic Neuritis in Multiple Sclerosis
Role: collaborator
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Role: lead
Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)
Role: collaborator
Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Role: lead
Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)
Role: lead
Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Role: lead
Randomized Safety Study of CVT-301 Compared to an Observational Control Group
Role: lead
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
Role: collaborator
SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Role: collaborator
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
Role: lead
AC105 in Patients With Acute Traumatic Spinal Cord Injury
Role: lead
A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis
Role: collaborator
Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
Role: lead
Study of Oral Fampridine-SR in Multiple Sclerosis
Role: lead
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Role: lead
A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users
Role: collaborator
Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes
Role: lead
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.
Role: lead